Unicycive Therapeutics (UNCY)

• Market cap: $90.6M
• 1 day: 5.56%
• 5 days: 8%
• 1 month: 33.25%
• 3 months: 5.77%
• 6 months: -19.84%
• Year to date: -35.23%
• 1 year: 22.73%
• 5 years: -91.23%
• 10 years: -91.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Employees: 22